COVID-19: Experimental Vaccine Records Huge Success in First Trial

Scientists are inching closer to developing a vaccine for the coronavirus following a report which stated that a COVID-19 experimental vaccine developed by Moderna Inc was safe and provoked immune responses all patients tested in an initial safety trial. 
Reuters reported that in the test conducted on Tuesday, July 14, patients who volunteered were given two doses of the vaccine. 

The team which carried out the trials reported that patients showed high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from the virus.
According to findings from the experiment which were also published in the New England Journal of Medicine, more than half of the volunteers experienced mild or moderate side effects like fatigue, headache, chills, muscle aches, or pain at the injection site. 

Bloomberg citing the report stated that three of 14 patients given the highest dose experienced severe side effects, but said that dose is not being used in larger trials. 

It was also disclosed that these reactions were likely to occur after the second dose and in people who got the highest dose.